USE OF NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF COGNITIVE FAILURE
摘要
Selective norepinephrine reuptake inhibitors, particularly atomoxetine, reboxetine and 2-alkylthio substituted phenoxyphenyl propylamines, are used for the treatment of cognitive failure, including cognitive failure due to dementia, delirium and schizophrenia.
申请公布号
WO03049724(A1)
申请公布日期
2003.06.19
申请号
WO2002US36132
申请日期
2002.11.27
申请人
ELI LILLY AND COMPANY;BYMASTER, FRANKLIN, PORTER;GEHLERT, DONALD, RICHARD;MCKINZIE, DAVID, LEE;YANG, CHARLES, RENKIN
